Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) today announced the ...

Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...

Researchers led by the University of Vienna and Liège University Hospital Center have identified genetic variants associated ...

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...

Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million ...

Belite Bio (BLTE) stock outlook: tinlarebant clinical data, 2026 filings, key FDA/EU risks, and $165/share valuation. See if ...

Rare diseases, though individually uncommon, collectively affect millions worldwide. Despite major advances in genome sequencing and interpretation of genomic data on affected individuals, for many ...